Financials data is unavailable for this security.
Cash flow in JPYView more
In 2023, K Pharma Inc increased its cash reserves by 144.34%, or 1.93bn. Cash Flow from Financing totalled 1.49bn or 148.62% of revenues. In addition the company generated 454.42m in cash from operations while cash used for investing totalled 11.10m.
Cash flow per share | -36.68 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 230.79 |
---|---|
Tangible book value per share | 230.79 |
More ▼
Balance sheet in JPYView more
Current ratio | 34.93 |
---|---|
Quick ratio | 34.85 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼